Agilent Technologies (U.S.), Bode Technology (U.S.), GE Healthcare (U.K.), Illumina (U.S.), LGC Forensics (U.K.), Orchid Cellmark, Inc. (U.S.), Promega Corporation (U.S.), QIAGEN N.V. (Netherlands), Thermo Fisher Scientific, Inc. (U.S.)
(PRWEB) July 18, 2014
The “Human Identification Market by Technology (Next Generation Sequencing, Rapid DNA Analysis, Capillary Electrophoresis, PCR), Application (Forensics, Paternity Testing), DNA Amplification, Quantification, Extraction, Services, & Software - Forecast to 2018”, provides a detailed overview of the major drivers, restraints, challenges, opportunities, current market trends, and strategies impacting the Human Identification market along with the estimates and forecasts of the revenue and share analysis.
The global market was valued at an estimated $419.4 million in 2013 and is expected to reach $804.0 million by 2018, growing at a CAGR of 13.9% between 2013 and 2018.
For More Inquiries @ http://www.marketsandmarkets.com/Enquiry_Before_Buying.asp?id=100607777
The report segments this market based on technology, application, products and services, and geography. Among various technologies, the capillary electrophoresis commanded the largest share in 2013, while next generation sequencing (NGS) is forecasted to be the fastest-growing segment in the market. Factors such as rising awareness regarding new technologies for the DNA analysis, government support in the form of funding, and the need to reduce time and cost associated with DNA analysis are driving the growth of market. Furthermore, owing to continuous advancements in technology, new and innovative products are being launched in the market which is another major factor providing impetus for growth of the market.
Based on geography, the global market is segmented into North America, Europe, Asia, and the Rest of the World (RoW). North America accounted for the largest share of the market in 2013. This large share of the North American region can be attributed various factors including expansion of the U.S. national DNA database and government support in the form of grants and funds.
The prominent players in the market are Thermo Fisher Scientific, Inc. (U.S.), Promega Corporation (U.S.), QIAGEN N.V. (The Netherlands), and Illumina (U.S.).
Browse Related Reports:
Gene Expression Analysis Market by Technology (DNA Microarray, Real-Time PCR, Next Generation Sequencing), Consumables (DNA Chips, Reagents), Services (Gene Profiling, Bioinformatics, Data Analysis Software) & Applications] - Global Forecast to 2018
Genomics Market by Products - [Instruments (NGS platform, Microarray, RT-PCR), Consumables (Genechips, Reagents for DNA Extraction & Purification, Sequencing)], Services (Sequencing & Microarray Services, and Software) - Global Forecast to 2018
MarketsandMarkets is a global market research and consulting company based in the U.S. We publish strategically analyzed market research reports and serve as a business intelligence partner to Fortune 500 companies across the world.
MarketsandMarkets also provides multi-client reports, company profiles, databases, and custom research services. MarketsandMarkets covers thirteen industry verticals, including advanced materials, automotive and transportation, banking and financial services, biotechnology, chemicals, consumer goods, energy and power, food and beverages, industrial automation, medical devices, pharmaceuticals, semiconductor and electronics, and telecommunications and IT.
We at MarketsandMarkets are inspired to help our clients grow by providing apt business insight with our huge market intelligence repository.
North - Dominion Plaza,
Suite 800, Dallas, TX 75252
Visit MarketsandMarkets Blog @ http://mnmblog.org/market-research/healthcare/biotechnology
Connect with us on LinkedIn @ http://www.linkedin.com/company/marketsandmarkets